Resources Repository
-
EditorialPublication 2021Scientific and Regulatory Challenges in Designing mHealth Interventions
Scientists looking for innovative ways to deliver health care have long searched for mechanisms that …
Scientists looking for innovative ways to deliver health care have long searched for mechanisms that can enable the right intervention to be delivered at the right time. Traditional delivery mechanisms have been limited both to the availability of a provider (e.g., a physician) and the location of care (e.g., a hospital or outpatient clinic). In recent years, however, numerous technological advancements—including wearable devices, mobile technologies, and the widespread development and use of user-friendly smartphone applications—have…
Science/Technology | North America | Technology Assessment | Health/Medicine -
NewsPublication 2020Online Anti-Vaccine Movement in the Age of COVID-19
This article discusses a recent report by the Centre for Countering Digital Hate (CCDH) that …
This article discusses a recent report by the Centre for Countering Digital Hate (CCDH) that lambasted social media companies for allowing the anti-vaccine movement to remain on their platforms. The CCDH report noted that social media accounts held by so-called anti-vaxxers have increased their following by at least 7-8 million people since 2019. “The decision to continue hosting known misinformation content and actors left online anti-vaxxers ready to pounce on the opportunity presented by coronavirus,”…
Science/Technology | North America | Preferences/Values | Infectious Diseases | Social Determinants | Culture/Society | Health/Medicine -
GuidelinesPublication 2016Estimating Health-State Utility for Economic Models: ISPOR Task Force Report
Cost-utility models are increasingly used in many countries to establish whether the cost of a …
Cost-utility models are increasingly used in many countries to establish whether the cost of a new intervention can be justified in terms of health benefits. Health-state utility (HSU) estimates (the preference for a given state of health on a cardinal scale where 0 represents dead and 1 represents full health) are typically among the most important and uncertain data inputs in cost-utility models. Clinical trials represent an important opportunity for the collection of health-utility data.…
Science/Technology | North America | Preferences/Values | Health Outcomes | Mathematical Models | Cost-Effectiveness Analysis | Technology Assessment | Health Systems | Health/Medicine | Europe